Metabolic effects and mechanisms for heart failure in South Asians

南亚人心力衰竭的代谢效应和机制

基本信息

  • 批准号:
    10642776
  • 负责人:
  • 金额:
    $ 147.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-07 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The goal of this project is to fill gaps in our understanding of early heart failure stages and of heart failure with preserved ejection fraction (HFpEF). Over half of all heart failure patients have HFpEF, and are more likely to be older, diabetic, obese, hypertensive and have a prognosis that is equally poor as those with reduced ejection fraction. No treatment has been shown to improve outcomes in patients with HFpEF, highlighting an urgent need to understand the heterogeneous phenotypes and underlying biologic and physiologic mechanisms for HFpEF. We have established a prospective cohort of South Asians called the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study that is closely tied to the Multi-Ethnic Study of Atherosclerosis (MESA) for efficient cross-ethnic comparisons. We have found that South Asians have significantly higher prevalence of diabetes and metabolic abnormalities, even with normal body mass index, compared to the four MESA race/ethnic groups. Additionally, South Asians have very high levels of fat stored in ectopic depots (in the liver, muscle and around the abdominal viscera). This unique cohort with its distinct phenotype can be leveraged to understand the metabolic effects and mechanisms involved in heart failure. In this proposed study, we will use the thorough baseline and repeated metabolic characterization of MASALA study participants and will measure heart failure stages among 850 MASALA participants in a new Exam 3. We will characterize heart failure stages by symptoms, dynamic echocardiography, NTproBNP, and HFpEF will be confirmed by exercise stress echocardiography. We propose to 1) determine the epidemiology of heart failure among middle to older aged South Asians and compare heart failure stages and HFpEF prevalence in South Asians to the four MESA race/ethnic groups. We will determine whether differences in heart failure stages and HFpEF prevalence between South Asians and MESA groups are mediated by differences in dysglycemia, ectopic fat and other metabolic factors; 2) determine whether endothelial dysfunction, arterial stiffness, and coronary microvascular dysfunction drive HFpEF in South Asians, and if they mediate the association between dysglycemia, adiposity, and HFpEF; and 3) determine the blood-based proteomic signatures of heart failure and HFpEF among South Asians. We will identify, verify, and validate the proteomics profile of heart failure and HFpEF, and determine the immunologic signatures characterizing HFpEF. We expect that South Asians will have a high prevalence of HFpEF, and that we will better define the phenotype and underlying mechanisms for HFpEF relevant for metabolically unhealthy but normal weight populations.
项目摘要 该项目的目标是填补我们对心力衰竭早期阶段和心力衰竭的理解的空白, 射血分数保留(HFpEF)。超过一半的心力衰竭患者患有HFpEF, 老年人、糖尿病患者、肥胖者、高血压患者,其预后与那些 射血分数没有任何治疗可以改善HFpEF患者的结局,这突出了 迫切需要了解异质性表型和潜在的生物和生理 HFpEF的机制。我们已经建立了一个南亚人的前瞻性队列,称为调解人, 生活在美国的南亚人的动脉粥样硬化(MASALA)研究与多民族研究密切相关 (MESA)进行有效的跨种族比较。我们发现南亚人 糖尿病和代谢异常的患病率明显较高,即使体重指数正常, 与四个MESA种族/族裔群体相比。此外,南亚人有非常高的脂肪储存水平, 异位贮库(肝脏、肌肉和腹部内脏周围)。这个独特的群体, 表型可以用来理解心力衰竭中涉及的代谢效应和机制。在 在这项拟议的研究中,我们将使用MASALA的全面基线和重复代谢特征 研究参与者,并将在新的检查3中测量850名MASALA参与者的心力衰竭阶段。我们 将通过症状表征心力衰竭阶段,动态超声心动图、NTproBNP和HFpEF将 经运动负荷超声心动图证实我们建议1)确定心力衰竭的流行病学 中老年南亚人,比较心力衰竭分期和HFpEF患病率, 亚洲人到四个MESA种族/民族群体。我们将确定心力衰竭阶段和 南亚人和MESA组之间的HFpEF患病率是由精神障碍的差异介导的, 异位脂肪和其他代谢因素; 2)确定是否内皮功能障碍,动脉僵硬, 冠状动脉微血管功能障碍驱动南亚人的HFpEF,如果它们介导了 心功能不全、肥胖和HFpEF; 3)确定心力衰竭的血液蛋白质组学特征 和HFpEF。我们将识别、验证和确认心力衰竭的蛋白质组学特征 和HFpEF,并确定表征HFpEF的免疫学特征。我们希望南亚人 HFpEF的患病率将很高,我们将更好地定义表型和潜在的 与代谢不健康但体重正常人群相关的HFpEF机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALKA M. KANAYA其他文献

ALKA M. KANAYA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALKA M. KANAYA', 18)}}的其他基金

Metabolic effects and mechanisms for heart failure in South Asians
南亚人心力衰竭的代谢效应和机制
  • 批准号:
    10421268
  • 财政年份:
    2021
  • 资助金额:
    $ 147.02万
  • 项目类别:
Metabolic effects and mechanisms for heart failure in South Asians
南亚人心力衰竭的代谢效应和机制
  • 批准号:
    10049526
  • 财政年份:
    2021
  • 资助金额:
    $ 147.02万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    10671645
  • 财政年份:
    2016
  • 资助金额:
    $ 147.02万
  • 项目类别:
Core A: Human Metabolism
核心A:人体新陈代谢
  • 批准号:
    10217107
  • 财政年份:
    2015
  • 资助金额:
    $ 147.02万
  • 项目类别:
Core A: Human Metabolism
核心A:人体新陈代谢
  • 批准号:
    10457900
  • 财政年份:
    2015
  • 资助金额:
    $ 147.02万
  • 项目类别:
Coronary artery cross-sectional area and cardiovascular risk in South Asians
南亚人的冠状动脉横截面积和心血管风险
  • 批准号:
    10176172
  • 财政年份:
    2013
  • 资助金额:
    $ 147.02万
  • 项目类别:
Ectopic fat and atherosclerosis in South Asians
南亚人的异位脂肪和动脉粥样硬化
  • 批准号:
    8441395
  • 财政年份:
    2013
  • 资助金额:
    $ 147.02万
  • 项目类别:
Coronary artery cross-sectional area and cardiovascular risk in South Asians
南亚人的冠状动脉横截面积和心血管风险
  • 批准号:
    10404115
  • 财政年份:
    2013
  • 资助金额:
    $ 147.02万
  • 项目类别:
Ectopic fat and atherosclerosis in South Asians
南亚人的异位脂肪和动脉粥样硬化
  • 批准号:
    8706951
  • 财政年份:
    2013
  • 资助金额:
    $ 147.02万
  • 项目类别:
Ectopic fat and atherosclerosis in South Asians
南亚人的异位脂肪和动脉粥样硬化
  • 批准号:
    9262958
  • 财政年份:
    2013
  • 资助金额:
    $ 147.02万
  • 项目类别:

相似国自然基金

细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
  • 批准号:
    81570244
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
  • 批准号:
    81171113
  • 批准年份:
    2011
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
靶向 A2B 腺苷受体用于胰腺癌的免疫预防
  • 批准号:
    10929664
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
Exploring the role of adenosine A2A receptors in Schizophrenia using opto-pharmacologically controlled allosteric modulation.
利用光药理学控制的变构调节探索腺苷 A2A 受体在精神分裂症中的作用。
  • 批准号:
    23K14685
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Role of Adenosine Kinase in Mixed Diastolic Heart Failure and Alzheimer Disease
腺苷激酶在混合性舒张性心力衰竭和阿尔茨海默病中的作用
  • 批准号:
    10679989
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
  • 批准号:
    BB/W016974/1
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
    Research Grant
Investigation of new test methods for adenosine-sensitive atrioventricular block
腺苷敏感型房室传导阻滞新检测方法的探讨
  • 批准号:
    23K07566
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
  • 批准号:
    10760676
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
The role of A1 adenosine receptor signaling in the decline of S. pneumoniae killing by neutrophils in vaccinated aged hosts
A1 腺苷受体信号传导在疫苗接种老年宿主中中性粒细胞杀伤肺炎链球菌下降中的作用
  • 批准号:
    10605737
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
Adenosine triphosphate as a master variable for biomass in the oceanographic context
三磷酸腺苷作为海洋学背景下生物量的主变量
  • 批准号:
    2319114
  • 财政年份:
    2023
  • 资助金额:
    $ 147.02万
  • 项目类别:
    Standard Grant
The Biology of Microglia: Adenosine A3 Receptor Suppression
小胶质细胞的生物学:腺苷 A3 受体抑制
  • 批准号:
    RGPIN-2019-06289
  • 财政年份:
    2022
  • 资助金额:
    $ 147.02万
  • 项目类别:
    Discovery Grants Program - Individual
Postnatal development of adenosine kinase in the brainstem network that controls breathing
控制呼吸的脑干网络中腺苷激酶的出生后发育
  • 批准号:
    573323-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 147.02万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了